Skip to main content
. 2025 Feb 26;17(5):813. doi: 10.3390/cancers17050813
Definitions
APC Antigen-presenting cells
CAF Cancer-associated fibroblasts (CAFs)
CD Cluster of Differentiation
CEACAM Carcinoembryonic antigen-related cell adhesion molecules
CRC Colorectal cancer
CTLA-4 Cytotoxic T-lymphocyte associated protein-4
CTX Chemotherapy
dMMR Deficient mismatch repair
DCA Deoxycholic acid
DC Dendritic cells
EBV Epstein Barr virus
ECM Extracellular matrix
FMT Fecal microbiota transplantation
5-FU 5-fluorouracil
GC Gastric cancer
HBV Hepatitis B virus
HCV Hepatitis C virus
HIF Hypoxia-inducible factor
HPV Human papillomavirus
HTLV-1 Human T-cell lymphotropic virus type 1
ICIs Immune checkpoint inhibitors
irAEs Immune-related adverse events
ITIM Immunoreceptor tyrosine-based inhibitory motifs
LAG-3 Lymphocyte activation gene 3
LPS Lipopolysaccharide
MDSCs Myeloid-derived suppressor cells
MSI-H Microsatellite instability-high
NK Natural killer
PDAC Pancreatic ductal adenocarcinoma
PD-1 Programmed cell death protein-1
PD-L1 Programmed cell death protein-1 ligand
PRR Pattern recognition receptors
ROS Reactive oxygen species
RT Radiation therapy
SCFA Short-chain fatty acids
TAMs Tumor-associated macrophages
TIM-3 T-cell immunoglobulin and mucin domain 3
TIME Tumor-immune microenvironment
TIGIT T-cell immunoglobulin and ITIM
TIL Tumor-infiltrating lymphocytes
TME Tumor microenvironment
Tregs Regulatory T cells